Xenetic Biosciences XBIO
NASDAQ XBIO
$2.24 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Xenetic Biosciences (XBIO) Return on Capital Employed [ROCE] (2012 - 2026)

Updated

Xenetic Biosciences (XBIO) posted Return on Capital Employed [ROCE] of -40.37% for Q2 2026, up 29.57 percentage points from -69.94% a year earlier but down 7.01 percentage points from the prior quarter.

Analysis

Xenetic Biosciences (XBIO) Return on Capital Employed [ROCE] (2012 - 2026) Analysis & Trends

For FY2025, Xenetic Biosciences' Return on Capital Employed [ROCE] came in at -42.53%, up 10.97 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of +42.32 percentage points (FY2020 to FY2025).
  • In prior years, Xenetic Biosciences' Return on Capital Employed [ROCE] was -53.50% in FY2024 (-15.40 pp), -38.10% in FY2023 (+3.39 pp), -41.48% in FY2022 (-3.36 pp) and -38.12% in FY2021 (+46.73 pp).
  • Quarterly Return on Capital Employed [ROCE] has run from a low of -80.77% in Q3 2025 to a high of -30.04% in Q4 2021 over five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased in each of the last three quarters, with an average year-over-year change of +0.02 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q4 2021, with a gain of 109.32 percentage points; the weakest was Q2 2024, with a drop of 29.07 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -33.36% (Q1 2026), -49.32% (Q4 2025) and -80.77% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Xenetic Biosciences 5.25 Mn -20.58 Mn - -40.37%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -40.37%
Mar 31, 2026 -33.36%
Dec 31, 2025 -49.32%
Sep 30, 2025 -80.77%
Jun 30, 2025 -69.94%
Mar 31, 2025 -68.30%
Dec 31, 2024 -63.90%
Sep 30, 2024 -57.91%
Jun 30, 2024 -65.67%
Mar 31, 2024 -52.45%
Dec 31, 2023 -43.12%
Sep 30, 2023 -42.74%
Jun 30, 2023 -36.60%
Mar 31, 2023 -45.00%
Dec 31, 2022 -47.73%
Sep 30, 2022 -46.95%
Jun 30, 2022 -47.39%
Mar 31, 2022 -33.62%
Dec 31, 2021 -30.04%
Sep 30, 2021 -34.00%
API Access

Xenetic Biosciences Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=XBIO&period=max&api_key=YOUR_API_KEY